Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 494 participants.
Also called NCT02049814
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 494 participants
- Sponsor
- Registry
-
NCT02049814
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02049814. Randomized; no masking; primary purpose treatment. Start 2014-05-09 (actual); primary completion 2016-06-01 (actual). Results posted on 2019-02-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Voglibose
- Intervention (Drug)
- Acarbose
- Lead sponsor
- Takeda
Record details
- Record id
cardio:ct-nct02049814- Content hash
bebb012757a53e6772b0e99884426c19a9205a60bd30c8aae2ec7c8f68eb6eb6